Meeting Report
Expert Insights on Triple-Negative Breast Cancer: Preparing for the Next Wave of Treatments
Presented by Heather R. Greene, MSN, FNP, AOCNP®, and Lee S. Schwartzberg, MD, FACP
From West Cancer Center & Research Institute, Memphis, Tennessee
Presenters’ disclosures of conflicts of interest are found at the end of this article.
J Adv Pract Oncol 2020;11(3):266–270 |
https://doi.org/10.6004/jadpro.2020.11.3.10 |
© 2020 Harborside™
ABSTRACT
Heather R. Greene, MSN, FNP, AOCNP®, and Lee S. Schwartzberg, MD, FACP, discussed the current and future treatment landscape for triple-negative breast cancer, including recent and emerging data on approved treatments, novel therapeutic options being investigated, and best practices for identifying and monitoring adverse events associated with PARP and immune checkpoint inhibitors at JADPRO Live 2019.
For access to the full length article, please
sign in.
